MC2R MODULATOR COMPOUNDS
The disclosures herein relate to novel compounds of Formula (1); or a salt thereof, wherein A, Z, X, L1, L2, L3, RA, RB, RC, RD, Y1 and Y2 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with the melanocortin subtype-2...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
29.08.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!